Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 69.11% is in line with its 5-year average of 68.21%, near the high end of its 5-year range (41.44%–70.50%).
0.40% above its 12-month average of 68.83%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 69.44%.
GROSS MARGIN
69.11%
GROSS MARGIN AVG TTM
68.83%
GROSS MARGIN AVG 3Y
67.88%
GROSS MARGIN AVG 5Y
68.21%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.40%
CURRENT VS 3Y AVG
+1.81%
CURRENT VS 5Y AVG
+1.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+67.72%
vs the sector median at left
Waystar Holding Corp.
Market Cap
$5.06B
Gross Margin
69.11%
TTM Avg
68.83%
3Y Avg
67.88%
5Y Avg
68.21%
Market Cap
$5.07B
Gross Margin
49.52%
TTM Avg
48.04%
3Y Avg
46.91%
5Y Avg
45.73%
Market Cap
$5.09B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-67.67%
5Y Avg
-188.00%
Market Cap
$5.19B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-37.83%
Market Cap
$5.20B
Gross Margin
54.72%
TTM Avg
55.10%
3Y Avg
55.18%
5Y Avg
55.10%
Market Cap
$5.21B
Gross Margin
94.41%
TTM Avg
97.28%
3Y Avg
95.66%
5Y Avg
96.11%
Market Cap
$5.21B
Gross Margin
-6537.01%
TTM Avg
-3376.01%
3Y Avg
-7968.48%
5Y Avg
-11525.78%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waystar Holding Corp. (WAY) | $5.06B | 69.11% | 68.83% | 67.88% | 68.21% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 49.52% | 48.04% | 46.91% | 45.73% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.09B | 0.00% | 0.00% | -67.67% | -188.00% |
| Erasca, Inc. (ERAS)vs › | $4.96B | 0.00% | 0.00% | 0.00% | 0.00% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.19B | 0.00% | 0.00% | 0.00% | -37.83% |
| Doximity, Inc. (DOCS)vs › | $5.20B | 88.07% | 89.65% | 88.97% | 88.20% |
| Sotera Health Company (SHC)vs › | $5.20B | 54.72% | 55.10% | 55.18% | 55.10% |
| Travere Therapeutics, Inc. (TVTX)vs › | $5.21B | 94.41% | 97.28% | 95.66% | 96.11% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.21B | -6537.01% | -3376.01% | -7968.48% | -11525.78% |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
69.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 69.44% |
| 2026-03-31 | 69.08% |
| 2025-12-31 | 69.48% |
| 2025-09-30 | 68.31% |
| 2025-06-30 | 67.84% |
| 2025-03-31 | 67.50% |
| 2024-12-31 | 67.41% |
| 2024-09-30 | 66.46% |
| 2024-06-30 | 65.70% |
| 2024-03-31 | 66.55% |
| 2023-12-31 | 67.49% |
| 2023-09-30 | 68.10% |
| 2023-06-30 | 69.13% |
| 2023-03-31 | 69.04% |
| 2022-12-31 | 70.50% |
| 2022-09-30 | 43.39% |
| 2022-06-30 | 42.64% |
| 2022-03-31 | 69.29% |
| 2021-12-31 | 41.44% |
| 2021-09-30 | 43.73% |
| 2021-06-30 | 44.49% |
| 2021-03-31 | 44.06% |
